Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Annual Follow-Up Study
Completed
200 enrolled
BRCA Mutations in Latinas
Completed
266 enrolled
Risk Communication Within Mexican-American Families
Completed
498 enrolled
Clinical, Genetic, Behavioral, Laboratory and Epidemiologic Characterization of Individuals and Families at High Risk of Breast/Ovarian Cancer
Completed
377 enrolled
Breast Mammogram and Tissue Study
Completed
466 enrolled
Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk
Completed
40 enrolled
Testing the Drug Atezolizumab or Placebo With Usual Therapy in First-Line HER2-Positive Metastatic Breast Cancer
Phase 3 Completed
190 enrolled 12 charts
Endoxifen in Adults With Hormone Receptor Positive Solid Tumors
Phase 1 Completed
40 enrolled
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by Surgery
Phase 2 Completed
454 enrolled 23 charts
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
Phase 3 Completed
305 enrolled 10 charts
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer
Phase 2 Completed
77 enrolled 17 charts
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer
Phase 3 Completed
3,270 enrolled 16 charts
An Exploratory Evaluation of Biomarkers in Blister Fluid in Healthy Volunteers and Irradiated Skin
Completed
61 enrolled
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
Phase 3 Completed
2,014 enrolled 16 charts
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
Phase 3 Completed
394 enrolled 11 charts
Cisplatin With or Without Veliparib in Treating Patients With Recurrent or Metastatic Triple-Negative and/or BRCA Mutation-Associated Breast Cancer With or Without Brain Metastases
Phase 2 Completed
344 enrolled
Azacitidine and Entinostat in Treating Patients With Advanced Breast Cancer
Phase 2 Completed
58 enrolled 16 charts
Eligibility Screening for the NIH Intramural Research Program Clinical Protocols
Completed
19,522 enrolled
Veliparib and Irinotecan Hydrochloride in Treating Patients With Cancer That Is Metastatic or Cannot Be Removed by Surgery
Phase 1 Completed
73 enrolled
Where Culture Meets Genetics: Exploring Latinas Causal Attributions of Breast and Colon Cancer and Models of Disease Inheritance
Completed
22 enrolled
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
Completed
484 enrolled
The Treatment of Stage I and II Carcinoma of the Breast With Mastectomy and Axillary Dissection Versus Excisional Biopsy, Axillary Dissection, and Definitive Irradiation
Phase 3 Completed
256 enrolled
Sorafenib in Treating Patients With Metastatic Breast Cancer
Phase 2 Completed
23 enrolled
Vaccine Therapy in Treating Patients With Metastatic Cancer
Phase 1 Completed
A Follow-up Study of Women Evaluated and Treated for Infertility
Completed
12,193 enrolled
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
Phase 2 Completed
43 enrolled 10 charts
Fulvestrant With or Without Bortezomib in Patients With Inoperable Locally Advanced or Metastatic Estrogen Receptor Positive Breast Cancer
Phase 2 Completed
118 enrolled 11 charts
Whole-Brain Radiation Therapy or Stereotactic Radiosurgery With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer
Phase 2 Completed
143 enrolled 24 charts
Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer
Phase 2 Completed
180 enrolled 46 charts
Follow-up Protocol for Patients With Cancer/AIDS/Skin Disease
Completed
1,031 enrolled
High-Risk Breast Duct Epithelium
Completed
156 enrolled
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
Phase 1 Completed
24 enrolled 12 charts
Paclitaxel, Nab-paclitaxel, or Ixabepilone With or Without Bevacizumab in Treating Patients With Stage IIIC or Stage IV Breast Cancer
Phase 3 Completed
799 enrolled 18 charts
Ad/HER2/Neu Dendritic Cell Cancer Vaccine Testing
Phase 1 Completed
33 enrolled 18 charts
ONC201 in Recurrent/Refractory Metastatic Breast Cancer and Advanced Endometrial Carcinoma
Phase 2 Completed
30 enrolled 15 charts
T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-DP0401 Positive
Phase 1/2 Completed
21 enrolled 22 charts
Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors
Phase 2 Completed
65 enrolled 11 charts
Self-Affirmation: Construct Validity
Completed
3,112 enrolled
T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
Phase 2 Completed
11 enrolled 12 charts
Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA Mutations
Phase 1/2 Completed
9 enrolled 11 charts
Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer
Phase 1/2 Completed
60 enrolled 6 charts
Safety and Tolerability of a Modified Vaccinia Ankara (MVA)-Based Vaccine Modified to Express Brachyury and T-cell Costimulatory Molecules (MVA-Brachyury-TRICOM)
Phase 1 Completed
38 enrolled 20 charts
The Ultrasound Study of Tamoxifen
Completed
247 enrolled
Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study
Completed
20 enrolled
Continuation of Follow-up of DES-Exposed Cohorts
Completed
10,805 enrolled
Extended Follow-up of Columbia, MO Serum Bank Participants
Completed
6,720 enrolled
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer
Phase 3 Completed
3,436 enrolled
Intestine Bacteria and Breast Cancer Risk
Completed
175 enrolled
Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
Completed
229 enrolled
Studying Normal Breast Tissue and Cancer Risk
Completed
13 enrolled